Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease Muriel NoetzliChin B. Eap Review Article 14 February 2013 Pages: 225 - 241
Anticoagulant Therapy with the Oral Direct Factor Xa Inhibitors Rivaroxaban, Apixaban and Edoxaban and the Thrombin Inhibitor Dabigatran Etexilate in Patients with Hepatic Impairment Jochen GraffSebastian Harder Review Article 07 February 2013 Pages: 243 - 254
Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dalcetrapib Mary PhelanJudith Anzures-CabreraDarren Bentley Original Research Article 12 February 2013 Pages: 255 - 265
Population Pharmacokinetics of Tranexamic Acid in Paediatric Patients Undergoing Craniosynostosis Surgery Susan M. GoobiePetra M. MeierLuis M. Pereira Original Research Article 01 February 2013 Pages: 267 - 276
Ciclosporin Population Pharmacokinetics and Bayesian Estimation in Thoracic Transplant Recipients Dorothée FruitAnnick RousseauAurélie Prémaud Original Research Article 12 February 2013 Pages: 277 - 288
Population Pharmacokinetics of Tobramycin in Patients With and Without Cystic Fibrosis Stefanie HennigJoseph F. StandingAlison H. Thomson Original Research Article 19 February 2013 Pages: 289 - 301